Survival of human stem cell-derived islets (HSCI) and function of human islets after transplantation into a pre-vascularised intracutaneous site created by the Novosorb® biodegradable temporising matrix (BTM)
Cell Transplantation · 2026-10 · 35
DOI: 10.1177/09636897261508947 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Transplantation, online erschienen am 20.11.2026. Verfasst von Christopher J. Drogemuller und 21 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Breakthrough T-1D, Juvenile Diabetes Research Foundation International.
Abstract (Originalsprache)
We evaluated a fully biodegradable polyurethane matrix (Novosorb® BTM) to create a vascularised intracutaneous site for human islet cell transplantation (ICT) outside of the liver. Pre-clinically, Human Stem Cell–derived Islets (HSCI) were implanted into the Novosorb® intracutaneous site in immunosuppressed pigs using an elliptical, foldable pocket and examined at days 7, 14, and 28. HSCI clusters were consistently identified throughout the intracutaneous site out to 28 days in pigs under immunosuppression. Clinically, INCEPTR was a prospective, single-centre, first-in-human pilot of intracutaneous allogeneic ICT in stable kidney transplant recipients with long-standing type 1 diabetes (T1D), with negative C-peptide at baseline. Primary endpoint: was detectable C-peptide (>10pmol/L) at 3 months. Three adult kidney transplant recipients underwent outpatient Novosorb® BTM implantation, and subsequent intracutaneous human ICT. One of three had detectable C-peptide at 3 months (primary end point), all had improved HbA1c (−0.6% to −1.3%) and reduced insulin requirement (−7% to −49%) over 12 months (pre-specified secondary endpoints). One participant has sustained long term graft function with detectable serum and urinary C-peptide and Mixed-Meal responsiveness at >3.5 years. Therefore, the pre-vascularised Novosorb® BTM intracutaneous site is capable of safely supporting human islet survival and function, albeit at a modest level, in an extrahepatic site that is retrievable, potentially supporting future cellular therapy platforms outside the liver. The study was prospectively registered on the Australian and New Zealand Clinical Trials Registry (ACTRN12621001573842) (https://www.anzctr.org.au) as ‘Intracutaneous ectopic pancreas’ - A prospective evaluation of a novel treatment for Type I Diabetes Mellitus employing deceased donor islets implanted into modified, pre-integrated Biodegradable Temporising Matrix (BTM) dermal replacement. Keywords: islet after kidney transplantation, intracutaneous, alternative site, Human Stem Cell Derived Islets (HSCI).
Förderung
- Breakthrough T-1D
- Juvenile Diabetes Research Foundation International
Zitieren
APA
Drogemuller, C. J., Penko, D., Nitschke, J., Johnston, J., Kireta, S., Concannon, E., Loudovaris, T., Rickard, A., Etherton, C., Hansson, M., Rescan, C., Toft, D. B., Vestergaard, B., Drummond, A., Overby, P., Jensen, V. S., Coghlan, P., Kay, T., Torpy, D. J., …, & AO, P. T. C. (2026). Survival of human stem cell-derived islets (HSCI) and function of human islets after transplantation into a pre-vascularised intracutaneous site created by the Novosorb® biodegradable temporising matrix (BTM). Cell Transplantation, 35. https://doi.org/10.1177/09636897261508947
Vancouver
Drogemuller CJ, Penko D, Nitschke J, Johnston J, Kireta S, Concannon E, et al. Survival of human stem cell-derived islets (HSCI) and function of human islets after transplantation into a pre-vascularised intracutaneous site created by the Novosorb® biodegradable temporising matrix (BTM). Cell Transplantation. 2026;35. doi:10.1177/09636897261508947
BibTeX
@article{Drogemuller2026,
author = {Drogemuller, Christopher J. and Penko, Daniella and Nitschke, Jodie and Johnston, Julie and Kireta, Svjetlana and Concannon, Elizabeth and Loudovaris, Thomas and Rickard, Alice and Etherton, Colleen and Hansson, Mattias and Rescan, Claude and Toft, Dorthe B. and Vestergaard, Bill and Drummond, Amy and Overby, Peter and Jensen, Victoria S. and Coghlan, Patrick and Kay, Tom and Torpy, David J. and Grey, Shane T. and Greenwood, John E. and AO, Patrick T. Coates},
title = {Survival of human stem cell-derived islets (HSCI) and function of human islets after transplantation into a pre-vascularised intracutaneous site created by the Novosorb® biodegradable temporising matrix (BTM)},
journal = {Cell Transplantation},
year = {2026},
volume = {35},
doi = {10.1177/09636897261508947}
}
EUVIMED